Docosahexaenoic acid-derived oxidized lipid metabolites modulate the inflammatory response of lipolysaccharide-stimulated macrophages
- 1 May 2018
- journal article
- research article
- Published by Elsevier in Prostaglandins & Other Lipid Mediators
- Vol. 136, 76-83
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Food and Agriculture
This publication has 38 references indexed in Scilit:
- Incorporation of eicosapentaenoic and docosahexaenoic acids into lipid pools when given as supplements providing doses equivalent to typical intakes of oily fishThe American Journal of Clinical Nutrition, 2012
- Omega-3 Fatty Acids and Inflammatory ProcessesNutrients, 2010
- Systems approach to inflammation resolution: identification of novel anti-inflammatory and pro-resolving mediatorsJournal of Thrombosis and Haemostasis, 2009
- The relationship between the fatty acid composition of immune cells and their functionProstaglandins, Leukotrienes and Essential Fatty Acids, 2008
- Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediatorsThe FASEB Journal, 2008
- Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediatorsNature Reviews Immunology, 2008
- Association of Low-Grade Inflammation with Nephropathy in Type 2 Diabetic Patients: Role of Elevated CRP-Levels and 2 Different Gene-Polymorphisms of Proinflammatory CytokinesExperimental and Clinical Endocrinology & Diabetes, 2007
- Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S‐hydroxy‐DHAThe FASEB Journal, 2006
- ResolvinsJournal of Experimental Medicine, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001